C
Creative Medical Technology Holdings, Inc. (CELZ)
NCM – Real Time Price. Currency in USD
1.97
-0.01 (-0.51%)
At close: Mar 27, 2026, 4:00 PM EDT
1.89
-0.08 (-4.06%)
After-hours: Mar 27, 2026, 7:07 PM EDT

NCM – Real Time Price. Currency in USD
1.97
-0.01 (-0.51%)
At close: Mar 27, 2026, 4:00 PM EDT
1.89
-0.08 (-4.06%)
After-hours: Mar 27, 2026, 7:07 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 25.97 | 6.05 | 10 | |
| Quick ratio | 25.97 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 89K | 9K | 11K | 6K | 6K |
| Gross Profit | -32K | -89K | -104K | -120K | -120K |
| Operating Income | -10M | -6M | -6M | -6M | -6M |
| Net Income | -10M | -5M | -5M | -6M | -6M |
| EBITDA | -10M | -6M | -6M | -6M | -6M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | -100 | 31.37 | 5.5 |
| Next year | N/A | 3.57 | 2.5 |
| Weighted average score | 2.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -52.72 | 22.92 | -65.79 | 5.5 |
| Y/Y | 0 | -1.8 | 66.06 | 0.62 | 3.5 |
| 3y average | -37.67 | 11.62 | 35.3 | 6.85 | 5.8 |
| 5y average | -31.74 | 6.99 | -1.67 | -57.82 | 2.0 |
| Weighted average score | 4.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $7.2M barely cover the upcoming debt maturities $0.0
Total current assets $7.4M exceed Total current liabilities $284.9K, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.9M limits the company's ability to reinvest or pay down debt